Evotec & Odyssey's AI Drug Discovery, Boyd Street's $100M Fund, & More

Hi there,

Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements in healthcare and life sciences AI. This week, we highlight a range of collaborations and innovations that are shaping the future of medical technology. CellCarta and Tempus AI, Inc. have joined forces to enhance oncology diagnostics, aiming to improve the development and commercial use of companion diagnostics in U.S. oncology practices. Meanwhile, Body Vision Medical has secured new funding to advance its AI-powered imaging technology for lung cancer diagnosis and treatment, supporting its global expansion.

In other news, ClaimsBridge has received investment from Eir Partners Capital and acquired DialysisPPO to enhance its AI-driven healthcare solutions, particularly in cost management for chronic dialysis treatment. Additionally, Evotec and Odyssey Therapeutics are collaborating to use AI in drug discovery for autoimmune and inflammatory diseases, aiming to accelerate the development of new treatments. These stories, among others, highlight the dynamic intersection of AI and healthcare, promising significant advancements in patient care and medical research.

Evotec and Odyssey Partner for AI-Driven Drug Discovery

Evotec and Odyssey Therapeutics have joined forces to leverage AI technology in the discovery of new treatments for autoimmune and inflammatory diseases. The collaboration focuses on using AI to identify promising small molecule drug candidates. Read more

Houston Methodist Study: Apella AI Boosts Surgery Efficiency

Research from Houston Methodist shows that using Apella's ambient AI in operating rooms increased surgical case volume by 7% and significantly reduced late-ending OR days. Read more

Boyd Street Capital Launches $100M AI HealthTech Fund

Boyd Street Capital has introduced HealthTech Platform Fund II, a $100 million fund targeting investments in AI-driven healthcare technology companies. The initiative is part of the firm's Mission 2030 strategy. Read more

GenScript and Tamarind Bio Partner for AI-Driven Molecular Validation

The collaboration between GenScript and Tamarind Bio aims to enhance the efficiency of molecular validation by integrating AI-powered design with experimental capabilities. Read more

Skye Africa and ECSA-HC Partner for AI Health Solutions in Eswatini

On August 5, 2026, Skye Africa Intelligence and the ECSA-HC announced a partnership to implement AI-enabled health solutions in Eswatini, focusing on disease tracking and mental health support. Read more

Aqurio Offers Free Trial of SmartAnalytics for Healthcare

Aqurio has launched a no-cost trial of its SmartAnalytics™ tool to help healthcare organizations improve patient access and recover lost revenue by analyzing patient interactions. Read more

Hyro Partners with ServiceNow for AI in Healthcare

Hyro has teamed up with ServiceNow to integrate AI agents into healthcare workflows, aiming to automate patient interactions and streamline administrative tasks. Read more

Community Health Network Implements Clarium AI for Surgical Supply Chain

Community Health Network in Indianapolis is using the Clarium AI platform to improve its surgical supply chain and reduce costs across its hospitals. Read more

Eli Lilly Partners with Veeva Systems for AI-Driven CRM

Eli Lilly has selected Veeva Systems' AI-driven Vault CRM to enhance its sales model and improve patient access to medications globally. Read more

Olio Labs Launches AI Platform for Clinical Trial Predictions

Olio Labs has introduced an AI-driven platform that enhances the accuracy of predicting human clinical trial outcomes, focusing on adverse events and toxicity. The platform uses AI models to analyze rodent behavior, offering predictions that are significantly faster and more accurate than traditional methods. Read more

IntelliTek Health and Promevo Partner for AI in Healthcare

IntelliTek Health and Promevo have formed a strategic partnership to enhance AI solutions in healthcare using Google Cloud. The collaboration aims to improve operational efficiency and expand clinical capacity for healthcare organizations. Read more

Fastino Labs Launches AI Models for Finance and Healthcare

Fastino Labs has introduced two AI models, Fastino-Nemotron-3.5-Lightning-Finance and Fastino-Nemotron-3.5-Lightning-Healthcare, optimized for financial and healthcare sectors using an autonomous fine-tuning agent. Read more

Mercyhealth and Vitea Collaborate on AI Governance

Mercyhealth has teamed up with Vitea to introduce an AI governance platform to enhance visibility, compliance, and accountability in its healthcare system. Read more

Body Vision Medical Secures Funding for AI Imaging

Body Vision Medical has secured new funding to enhance its AI-powered imaging technology for lung cancer diagnosis and treatment, with plans for global expansion. Read more

Zifo's SiEE Event Highlights AI Data Governance in Biopharma

At the 2026 SiEE in Basel, Zifo gathered biopharma experts to discuss the importance of data governance amidst AI advancements. Read more

Aureka Biotechnologies Secures $100 Million for AI Drug Discovery

Aureka Biotechnologies has completed a $100 million Series B funding round to advance its AI-driven drug discovery and develop a biological world model. Read more

ClaimsBridge Secures Investment and Acquires DialysisPPO

ClaimsBridge has received a strategic investment from Eir Partners Capital and acquired DialysisPPO to enhance its AI-driven healthcare solutions, particularly in cost management for chronic dialysis treatment. Read more

CellCarta and Tempus AI Partner for Oncology Diagnostics

CellCarta has partnered with Tempus AI, Inc. to enhance oncology diagnostics by including Tempus in its CDx Commercialization Lab Network, aiming to streamline diagnostic development for biopharma sponsors. Read more

Renew Biotechnologies Publishes AI Research on Neurodegeneration

Renew Biotechnologies has published research demonstrating the use of DNA methylation analysis to identify neuron-associated cell-free DNA signatures in blood, related to neurodegenerative diseases. Read more

LCMC Health Partners with Qualified Health for AI Integration

LCMC Health has partnered with Qualified Health to integrate generative AI into its healthcare system, aiming to enhance patient care and reduce administrative burdens. Read more

Kyndryl to Acquire Healthcare IT Leaders

Kyndryl plans to acquire Healthcare IT Leaders, LLC to boost its AI-led modernization services for U.S. healthcare organizations. The acquisition aims to integrate consulting and application managed services expertise, with completion expected in fiscal year 2027, pending regulatory approval. Read more

Categories

Companies

Resources

Evotec & Odyssey's AI Drug Discovery, Boyd Street's $100M Fund, & More - Life AI Weekly #80

We hope you enjoyed this article.

More from: Life Sciences

Subscribe to Life AI Weekly